MedTech News
Novel antibiotic targets IBD—and AI predicted how it would work before scientists could prove it
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases (IBD), but also successfully used a new type of AI to predict exactly how the drug works. To their knowledge, this is a global first for the AI.
High-density brain probe reveals distinctive electrical patterns of cell types during behavior
Trying to document how single brain cells participate in networks that govern behavior is a daunting task. Brain probes called Neuropixels, which feature high-density silicon arrays, have enabled scientists to collect electrophysiological data of this nature from a variety of animals
AI chatbots often outperform doctors in diagnosis, but need safeguards to avoid overprescribing
If you’ve been to a medical appointment recently, you may have already interacted with AI. As you describe your symptoms to the doctor, they may ask your permission to use an “AI scribe” to convert audio into medical notes in real time.
AI maps how a new antibiotic targets gut bacteria
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
Plexāā launches Bloom43 wearable breast surgery prep device
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.
FDA approves IceCure cryoablation for breast cancer
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted marketing authorization for its ProSense cryoablation system for breast cancer.
Hologic gains FDA clearance for GI pathogen detection assays
Hologic’s FDA clearance for its Panther Fusion GI Bacterial and Expanded Bacterial Assays represents the company’s entry into the gastroenteritis test market.
LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer
SAN DIEGO, Oct. 1, 2025 /PRNewswire/ — A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers and artificial intelligence, to transform lung cancer screening by making early detection both highly effective and cost-efficient for broad populations, including those in low- and middle-income countries.